The Supreme Court has sent a special message to the ‘youth of India’ — drug use is not “cool”. In a year-ender judgment, a Bench headed by Justice B.V. Nagarathna urged adolescents and ...

Considering the lack of regulatory provisions further posing risks to patient safety, the Central Drugs Standard Control ...

India had no legislation on narcotic substances until November 1985, when it brought in a law including a ban on the use of cannabis. The Narcotic Drugs and Psychotropic Substances Act ...

Suvendu Adhikari alleges a director of the pharma that supplied the drug acts as a ‘bridge’ between the firm and ‘Kalighat’, ...

The US FDA has approved the anti-diabetic drug Zepbound (Tirzepatide) for managing obstructive sleep apnea (OSA) in obese adults. Eli Lilly plans to launch the drug in India by 2025, pending ...

The company plans to implement a "competitive and appropriate" pricing strategy tailored for India, reflecting the drug’s efficacy in reducing the health and economic burden of chronic ...